chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was tired all day and about 2 am I woke up having abdominal pain and temperature of 104.7 and a few days before when I had the vaccination reaction I had the same temperature. So my daughter said I looked very unwell and that is when we realized it was more than just not feeling so great. She took me to the hospital to the ER and they admitted me for 2 nights. They ran a lot of tests I know they did a scan and blood work I was treated with IV fluids and antibiotics and I was taking generic form of fragile for 5 days and had a follow up with a gastroenterology and was in a very bland diet for a while. And I had never had Diverticulitis before and I was diagnosed with that which was a very huge surprise.
Syncopal episode, eyes rolled back, 2 tonic clonic jerks and then awake and alert. Episode lasting 30-40 seconds.
shriveled down and lost it; This is a spontaneous report from a contactable consumer (patient's daughter). An 80-year-old female patient received the second dose of BNT162b2 (PFIZER-BIOTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date, at patient age of 80-year-old, as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had to go into the emergency room and have 4 bags of potassium pumped into her because she just shriveled down and lost it and they didn't know what was wrong with her at one hospital so she went to another hospital and was there for 3 days. The reported wanted to know if these are side effects or something else. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Came into office on 2/25/00, with complaint of chills, fever of 101.6, face flushed, visable tremors around jaw line and cheeks, stated she "felt cold". Sent to see Dr. as soon as possible. Imm. as below on 2/24/00.
The next day after vaccine, the patient had difficulty breathing/fever/diarrhea/loss of appetite the next today that required ER visit. Pt sent home on oxygen concentrators and still has difficulty breathing at this point. Family theorizes that it could be related to adverse reaction from vaccine due to ADHD condition.
Within 10 minutes post vax, pt developed an injection site reaction characterized by an area of erythema measuring 6 cm in diameter with itching. The erythema lasted four days. The pt took Tylenol and recovered. This is one of four pts from this facility who experienced an injection site reaction following receipt of vax.
Patient began having intermittent  facial swelling that started on 4/5/2021. She received her second dose of Moderna 04/13/2021, LOT #046A21A, IM, Right arm. Patient presented to the clinic for evaluation 4/15/2021 with facial swelling that progressively worsened, no new food, medications or other environmental factors that patient are aware of. The swelling was associated with Trismus as well. Patient treated with 125 mg Solumedrol IM and set home with a medrol dose pack to begin the next day.
SkinRash, CoughWheeze, Rash, UrticariaPruritus,  throat swelling not characterized by anaphylaxis  Narrative: Report one hour following Vac #2, she felt a difficulty in swallowing. She did not go to ER, took benadryl x 4 days and used albuterol inhaler for the wheezing.
Date of Service Aug-24-2022 0902  Date of Admission Admit Date: Aug-21-2022  Date of Discharge Date of discharge Aug-24-2022  Allergies Penicillin - .  Chief Complaint Weakness  Procedure(s) Performed None  Lab Results Aug-24-2022 0520 Hematology WBC  3.9RBC  3.79HGB  11.0HCT  33.0MCV  87.1MCH  29.0MCHC  33.3RDW  14.8RDWSD  47.6PLT  189MPV  9.4AUTONEU%  54.9AUTOLYM%  29.3AUTOMON%  11.1AUTOEOS%  3.6AUTOBAS%  0.8AUTONEU#  2.1AUTOLYM#  1.1AUTOMON#  0.4AUTOBAS#  0.0AUTOEOS#  0.1NRBC%  0.0NRBC  0.0HGB/HCT  3.0IG#  0.01IG%  0.3 Aug-24-2022 0520 Chemistry GLUCOSE  95BUN  6CREAT  0.4MDRD GFR  162NA  146K  3.4CL  108CALCIUM  8.3CO2  32.0OSMO  288.0ANION GP  9.4BUN/CRE  15.0 Aug-23-2022 0445 Chemistry HGBA1C  4.2CRP  2.30 Aug
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 03-JUN-2015, the patient was vaccinated with an improperly stored dose of (Merck) VARIVAX (administration route, lot number and expiration date were not provided). No concomitant therapies were reported. No adverse effects were reported. This is one of two reports from the same reporter. Additional information has been requested.
dark spot (yellowish in color) at the bend of his elbow running up to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (dark spot (yellowish in color) at the bend of his elbow running up to the injection site) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced SKIN DISCOLOURATION (dark spot (yellowish in color) at the bend of his elbow running up to the injection site). At the time of the report, SKIN DISCOLOURATION (dark spot (yellowish in color) at the bend of his elbow running up to the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported Treatment information was not reported
ears ringing pressure in head; Taste changed can''t eat bell peppers that I used to love, numerous other foods taste like decomposed metallic taste; ears ringing pressure in head; This is a spontaneous report from a non-contactable consumer. A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 2 via an unspecified route of administration on Sep2021 (Batch/Lot Number: fdo809) as dose 2, single (at the age of 59 years old) for COVID-19 immunisation.  The patient had no medical history. There were no concomitant medications. Patient had no known allergies. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 on Oct2021 (Batch/Lot Number: ewo168) for COVID-19 immunisation. The patient experienced taste changed and can't eat bell peppers that he used to love, numerous other foods taste like decomposed metallic taste, ears ringing pressure in head on an unspecified date. The events were reported to have led to disability. The patient received no treatment. The outcome of the events was not recovered.   No follow up attempts are possible. No further information is expected.
Onset of chronic dermatitis associated within initiation of Anthrax vaccine. Persistent flares in dermatitis, 4 1/2 months since last dose.
This is a spontaneous report from a contractible registered medical assistant (RMA) via a sales representative. A 3-year-old male patient received a dose of PREVNAR13 on 06AUG2010 as a catch up suppl3ekental vaccine. The patient's relevant medical history, past drug history, and concomitant medications were unknown. No other vaccines were given. Within a day or two after the vaccine was given, there was a red "knot" on the injection site and it was warm to touch. There was no relevant lab test done, diagnosis or treatment given. In AUG2010, within 24 hours, the adverse events were gone and patient had recovered from the events.
Information has been received from a registered nurse concerning a 65 year old female nurse with allergies to most antibiotics, who on 13-OCT-2007 was vaccinated intramuscularly in the left deltoid with a dose of PNEUMOVAX 23 (Lot# 655765/0061U). On 12-OCT-2007, concomitant therapy included influenza virus vaccine (unspecified), administered in the right arm. On 13-OCT-2007 the patient experienced pain, redness, swelling, an area that was hot to the touch, and a temperature over 101F. The patient was seen at the physician's office and was diagnosed with cellulitis. The patient was treated with penicillin. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional has been requested has been requested.
Per Dr office the child was vaccinated on 05/07/07. Mother noticed the child developing a rash from head to toe on 05/08/07. Child was evaluated by DR on 05/09/07, no medications were given the patient was put on observation and evaluated again on 05/11/07. Dr indicated child doing well and rash resolving.
I have genital herpes, about this time of the day, I began to have symptoms of an "outbreak".  I called the pharmacy to ask if I could take my medicine (Famvir) and she said "no" - it would interfere with the shingles vaccine.
Phone call received from Mother 5/3/2023 at 1230 - details of the call and follow-up phone call 5/4/2023. Mother reported patient received her Men B and Men A 5/2/2023 in her RT Deltoid. Patient reported numbness and tingling to her RT arm and RT leg started approximately 2hrs after the administration. Mother reported RT arm appeared hot the rest of the evening. Patient participated in her soccer practice 5/2/2023 evening. Patient reported feeling nauseated after practice - she had a small amount of taco salad for dinner at 2230. Patient continued to c/o nausea overnight (no vomiting) and did not attend school 5/3/2023 due to nausea and c/o sore muscles (all over); numbness and tingling in RUE and RLL persisted all night 5/2/2023. Mother went home on her lunch break to check on Patient. Patienthad not eaten since the small portion of taco salad and had drank approximately 16oz of water 5/3 morning. Mother reported Patient appeared "gray" and Patient reported she felt like she was going to throw-up (persistent nausea); no vomiting. Patient reported her vision was abnormal and was "closing in" when she felt like she was going to throw-up. Mother reported Patient was "drenched" during the episode. When Patient went to the bathroom her extremities began to tense-up (started with hands and feet and progressed) and Patient could not move her extremities (sitting on the bathroom floor) - extremities appeared rigid per Mother and the symptom lasted approximately 10minutes and Mother reported Patient's extremities appeared red. No loss of consciousness. Mother called EMS and reported EMS evaluation/vital signs/EKG/and glucose were within normal limits. Patient was not transported to ED. Glucose 89. HR 72 and BPs 130/? and then 120/? - mother could not recall specifics of BP. Mother asked for guidance during call - Continue close observation; push fluids (goal of 120oz/day) and diet as tolerated. Seek Care if symptoms recur. Mother informed vaccine reaction would be reported. Mother verbalized understanding. No fever or illness prior to vaccine administration. Daily medications: Iron; Vitamin D; Accutane (no recent dose adjustment)
Patient developed left arm pain several hours after vaccine that has persisted until today and associated with reduced range of motion on exam and no signs of infection (no fevers, redness, swelling). I suspect a bursitis/SIRVA and am referring to physicla therapy today with follow up afterward.
racing heart rate and throat was itchy. slight blurry vision  patient received IM Benadryl 50 mg  symptoms resolved 30 minutes later
Pt has received their 2nd dose from a pharmacy intern 6 days prior to the 21 day due date (and 2 days prior to the 4 day grace period). Pt's parents have been informed that the dose is invalid and will need to come in for another vaccination.
Child  came in to receive vaccine with mother. Age was not verified and patient was given the Moderna vaccine. I asked patient her age after receiving vaccine and she told me she is 17. I talked to her and her mom about incident and filed an incident report.
Patient developed significant bilateral pulmonary emboli which she correlates with bivalent booster. Per patient she was told pulmonary emboli has been progressing for about 6 months.
hurting a little bit; redness; A spontaneous report was received from a Consumer concerning a 70 Years-old male patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness at the site of injection and was hurting a little bit.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 8 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch: 027L20A) in the left arm for prophylaxis of COVID-19 infection  On 14 Jan 2021, The patient experienced redness at the site where he received the shot and was hurting a little bit. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the events (redness and was hurting a little bit at injection site) was not resolved.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
body was super achy; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced general body pain. On an unknown date, the outcome of the general body pain was recovered/resolved.   It was unknown if the reporter considered the general body pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient had received first dose of shingles vaccine. The next day the patient's body was super achy. It only lasted for a day.
14 X 9 CM AREA OF INDURATION, REDNESS, AND WARMTH DEVELOPED AT THE INJECTION SITE 7/24/08.  DIPHENHYDRAMINE WAS GIVEN FOR AN URTICARIAL REACTION.
COVID vaccine breakthrough case, Pfizer 4/21/21 EW0150, 5/13/21 EW0179, and boosted 12/27/21 FL3198
Pain, redness, swelling at injection site. Prescribed CIPRO, ANAPROXIN
This case was reported by a consumer and described the occurrence of fever in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, several hours after receiving SHINGRIX, the patient experienced fever. The patient was treated with Aspirin. On an unknown date, the outcome of the fever was recovered/resolved. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient. The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient recently had the first dose of SHINGRIX. That evening, the patient ran a slight fever of 100.5 degree F. After taking 3 doses of aspirin over the next 12 hours, fever was gone. The patient was asking that this was just a known side effect, not an allergy and should proceed to have the second dose of SHINGRIX when it was due. Lab Comments: On an unknown date, the patient's body temperature was recorded as 100.5 degree F.
Headache, Myalgia, Arthralgia, right sided neck pain, really tired Narrative:
I THOUGHT I WAS DYING; BUTT AND LEG NUMB; BUTT PAIN; LEG PAIN; SO HOT; WEAKNESS; DANGEROUS FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. Batch/Lot number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced i thought i was dying, butt and leg numb, leg numb, butt pain, leg pain, so hot, weakness, and dangerous fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dangerous fever, so hot, weakness, i thought i was dying, butt numb and leg numb, leg numb, butt pain and leg pain was not reported. This report was non-serious.
Her whole arm hurts. Hurts most on her deltoid and travels down her arm. Has seen MD to get labs done and neurology exam.
polymyalgia seemed reduced/ improvement of around 50 percent; This is a spontaneous report received from contactable other healthcare professional. The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 22Mar2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "polymyalgia rheumatica", start date: May2020 (unspecified if ongoing). Concomitant medication included: PREDNISONE. Vaccination history included: BNT162B2 (dose 1, Batch/Lot number: unknown), administration date: 01Mar2021, for COVID-19 immunisation, reaction: "no negative symptoms". The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 24Mar2021, outcome "unknown", described as "polymyalgia seemed reduced/ improvement of around 50 percent".  Additional information: In late May2020, the patient was diagnosed with polymyalgia rheumatica. It came on almost suddenly. His legs became weak as he attempted to stand up after sitting an hour or so. His arms, especially his left, became uncomfortably sore when he tried to put on a coat. He could not raise it without pain when flexed but many times the pain lessened if he held it straight out. His neck became stiff all the time, being unable to turn my head to the left to check for cars while driving, so had to rotate his whole body in the car seat. Same but a bit less on the right. He also became more fatigued, retiring around 10:00 PM. He would awaken around 5:00 AM wanting to get up and move around. He would then be tired and would take an early nap or wait until later and nap for about 50 minutes. Things seemed a bit better until around 9:30 when the pains increased. He believed he was started on about 15 mg of prednisone/day and then began a reducing dosage of 1 mg/month on the 1st of every month. So each month reduced by 1 mg/day to the point he was at now, 3mg/day. In 01Apr (unspecified year), he then reduced to 2 mg/day, 01May (unspecified year) down to 1 mg/day until June 1st (unspecified year) when he stopped prednisone. So this pain has really been classic polymyalgia rheumatica. However, even with improvements, it was still "vary" annoying. Then he went and received his 1st Pfizer vaccine on 01Mar2021. Then following protocol he returned for his second Pfizer dose on 22Mar2021. After the second dose, he realized that his polymyalgia seemed reduced and by 2 days after the second vaccine he felt a definite reduction in the pain, and in the fatigue. There has been an improvement of around 50 percent. He was being alert for signs after receiving the vaccines, but never dreamed he would feel better. From reading, he did find out that a possibility of a virus being involved has been considered. The patient mentioned that he had no negative symptoms from the vaccine doses at all.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 lot # K021030, expiration date: 22-JUN-2016 (dose, route and site of administration were not reported). No adverse effects were reported. Follow up information has been received from the pharmacist on 09-NOV-2015. On 26-AUG-2015, the patient was vaccinated with dose of improperly stored PNEUMOVAX 23. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested. Patient details, suspect therapy, event data and narrative were updated.
FELT THROAT TIGHTEN; This spontaneous report received from a parent concerned a male of unspecified age.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 15-JUL-2021 11:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 15-JUL-2021, the subject experienced felt throat tighten. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt throat tighten on 15-JUL-2021. This report was non-serious.
No adverse effect; 17 year old patient was accidently administered an adult dose of VAQTA; This spontaneous report as received from a medical assistant refers to a 17 year old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported.  On an unknown date in February 2019, a 17 year old patient was accidentally vaccinated with an adult dose of hepatitis a vaccine, inactivated(VAQTA) injection 50/1.0 units/milliliter (dose and frequency was not reported) (lot # S001485, expiry date: 12-MAY-2020) intramuscularly for prophylaxis (incorrect dose administered). No adverse effects were reported. No product quality compliant was involved.
Child received GARASIL #2 on 10-21-08 - 2pm. Mom gave Vit D p.o 9pm 10-21-08 - Started with skins rash, numbness, throat swelling. Treated at ED after syms started. IV steroid given with EPI-PEN. Dr at ED voiced felt it was allergic reaction to vit D, not GARDASIL. No reaction previous GARDASIL given 7-22-08.
Fatigue, stomach ache - stayed home 3 days - MD called - resulting in labs ordered. All labs WNL.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Feet - elevated feet on chair
Death; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2021 and was forwarded to Moderna on 28-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Death) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            No treatment information was provided.  No concomitant medication was provided.; Sender's Comments: This is a 68-year-old, male patient who received mRNA-1273 vaccine (batch no. unknown) who died, on an unknown date after receiving first dose of vaccine.  No medical history or conmeds were provided. Existing comorbidities probably could have been the causative factor in his death. Very limited information has been reported at this time. Further information is expected.; Reported Cause(s) of Death: unknown cause of death